Clinical Trial Update: Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating captopril for efficacy in COVID-19 patients with pneumonia (CAPTOCOVID).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Pneumonia

Drugs mentioned

• CAPTOPRIL (Captopril)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pneumonia, Coronavirus Infection | Phase 2 | Status: UNKNOWN